These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 24050596)

  • 1. Decision aids for breast cancer chemoprevention.
    Juraskova I; Bonner C
    Breast Cancer Res; 2013; 15(5):106. PubMed ID: 24050596
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Informed choice about breast cancer prevention: randomized controlled trial of an online decision aid intervention.
    Korfage IJ; Fuhrel-Forbis A; Ubel PA; Zikmund-Fisher BJ; Greene SM; McClure JB; Smith DM; Alford SH; Fagerlin A
    Breast Cancer Res; 2013; 15(5):R74. PubMed ID: 24004815
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decision making in the context of breast cancer chemoprevention: patient perceptions and the meaning of risk.
    Holmberg C
    Am Soc Clin Oncol Educ Book; 2015; ():e59-64. PubMed ID: 25993227
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Perceptions of Racially and Ethnically Diverse Women at High Risk of Breast Cancer Regarding the Use of a Web-Based Decision Aid for Chemoprevention: Qualitative Study Nested Within a Randomized Controlled Trial.
    Jones T; Guzman A; Silverman T; Freeman K; Kukafka R; Crew K
    J Med Internet Res; 2021 Jun; 23(6):e23839. PubMed ID: 34100769
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pilot study of decision support tools on breast cancer chemoprevention for high-risk women and healthcare providers in the primary care setting.
    Kukafka R; Fang J; Vanegas A; Silverman T; Crew KD
    BMC Med Inform Decis Mak; 2018 Dec; 18(1):134. PubMed ID: 30558581
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patient and Provider Web-Based Decision Support for Breast Cancer Chemoprevention: A Randomized Controlled Trial.
    Crew KD; Bhatkhande G; Silverman T; Amenta J; Jones T; McGuinness JE; Mata J; Guzman A; He T; Dimond J; Tsai WY; Kukafka R
    Cancer Prev Res (Phila); 2022 Oct; 15(10):689-700. PubMed ID: 35679576
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Women's preferences for selective estrogen reuptake modulators: an investigation using protection motivation theory.
    Ralph AF; Ager B; Bell ML; Collins IM; Andrews L; Tucker K; Phillips KA; Butow P
    Patient Educ Couns; 2014 Jul; 96(1):106-12. PubMed ID: 24856850
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Making Informed Choices On Incorporating Chemoprevention into carE (MiCHOICE, SWOG 1904): Design and methods of a cluster randomized controlled trial.
    Crew KD; Anderson GL; Arnold KB; Stieb AP; Amenta JN; Collins N; Law CW; Pruthi S; Sandoval-Leon A; Bertoni D; Grosse Perdekamp MT; Colonna S; Krisher S; King T; Yee LD; Ballinger TJ; Braun-Inglis C; Mangino D; Wisinski KB; DeYoung CA; Ross M; Floyd J; Kaster A; Vander Walde L; Saphner T; Zarwan C; Lo S; Graham C; Conlin A; Yost K; Agnese D; Jernigan C; Hershman DL; Neuhouser ML; Arun B; Kukafka R
    Contemp Clin Trials; 2024 Jul; 142():107564. PubMed ID: 38704119
    [TBL] [Abstract][Full Text] [Related]  

  • 9. What Factors Influence Decision-Making about Breast Cancer Chemoprevention among High-Risk Women?
    Crew KD
    Cancer Prev Res (Phila); 2017 Nov; 10(11):609-611. PubMed ID: 28978567
    [TBL] [Abstract][Full Text] [Related]  

  • 10. How should we inform women at higher risk of breast cancer about tamoxifen? An approach with a decision guide.
    McKay A; Martin W; Latosinsky S
    Breast Cancer Res Treat; 2005 Nov; 94(2):153-9. PubMed ID: 16261414
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Women's decisions regarding tamoxifen for breast cancer prevention: responses to a tailored decision aid.
    Fagerlin A; Zikmund-Fisher BJ; Nair V; Derry HA; McClure JB; Greene S; Stark A; Hensley Alford S; Lantz P; Hayes DF; Wiese C; Claud Zweig S; Pitsch R; Jankovic A; Ubel PA
    Breast Cancer Res Treat; 2010 Feb; 119(3):613-20. PubMed ID: 19908143
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Addressing barriers to uptake of breast cancer chemoprevention for patients and providers.
    Crew KD
    Am Soc Clin Oncol Educ Book; 2015; ():e50-8. PubMed ID: 25993215
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemoprevention Uptake among Women with Atypical Hyperplasia and Lobular and Ductal Carcinoma
    Trivedi MS; Coe AM; Vanegas A; Kukafka R; Crew KD
    Cancer Prev Res (Phila); 2017 Aug; 10(8):434-441. PubMed ID: 28611039
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deciding on breast cancer risk reduction: The role of counseling in individual decision-making - A qualitative study.
    Blakeslee SB; McCaskill-Stevens W; Parker PA; Gunn CM; Bandos H; Bevers TB; Battaglia TA; Fagerlin A; Müller-Nordhorn J; Holmberg C
    Patient Educ Couns; 2017 Dec; 100(12):2346-2354. PubMed ID: 28734560
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decision aids for people facing health treatment or screening decisions.
    Stacey D; Bennett CL; Barry MJ; Col NF; Eden KB; Holmes-Rovner M; Llewellyn-Thomas H; Lyddiatt A; Légaré F; Thomson R
    Cochrane Database Syst Rev; 2011 Oct; (10):CD001431. PubMed ID: 21975733
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of web-based decision support to improve informed choice for chemoprevention: a qualitative analysis of pre-implementation interviews (SWOG S1904).
    Michel AM; Yi H; Amenta J; Collins N; Vaynrub A; Umakanth S; Anderson G; Arnold K; Law C; Pruthi S; Sandoval-Leon A; Shirley R; Perdekamp MG; Colonna S; Krisher S; King T; Yee LD; Ballinger TJ; Braun-Inglis C; Mangino DA; Wisinski K; DeYoung CA; Ross M; Floyd J; Kaster A; VanderWalde L; Saphner TJ; Zarwan C; Lo S; Graham C; Conlin A; Yost K; Agnese D; Jernigan C; Hershman DL; Neuhouser ML; Arun B; Crew KD; Kukafka R
    BMC Med Inform Decis Mak; 2024 Sep; 24(1):272. PubMed ID: 39334347
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of factors that influence the decision to take chemoprevention in patients with a significant family history of breast cancer: results from a patient questionnaire survey.
    Jones S; Hogan B; Patel K; Ooi S; Turton P; Achuthan R; Kim B
    Breast Cancer Res Treat; 2021 May; 187(1):207-213. PubMed ID: 33389407
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NRG Oncology/National Surgical Adjuvant Breast and Bowel Project Decision-Making Project-1 Results: Decision Making in Breast Cancer Risk Reduction.
    Holmberg C; Bandos H; Fagerlin A; Bevers TB; Battaglia TA; Wickerham DL; McCaskill-Stevens WJ
    Cancer Prev Res (Phila); 2017 Nov; 10(11):625-634. PubMed ID: 28978566
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Uptake of breast cancer preventive therapy in the UK: results from a multicentre prospective survey and qualitative interviews.
    Hackett J; Thorneloe R; Side L; Wolf M; Horne R; Cuzick J; Smith SG
    Breast Cancer Res Treat; 2018 Aug; 170(3):633-640. PubMed ID: 29687178
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Web-based decision aids to support breast cancer screening decisions: systematic review and meta-analysis.
    Yu L; Li P; Yang S; Guo P; Zhang X; Liu N; Wang J; Zhang W
    J Comp Eff Res; 2020 Oct; 9(14):985-1002. PubMed ID: 33025800
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.